KRISTY WINTERS: Open Payments
NPI 1538845656 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 14 payments from 10 companies in 2025. Trend: 2023 $15 · 2024 $356 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Madrigal Pharmaceuticals | 2 | $41 |
| Ardelyx, Inc. | 2 | $37 |
| GENZYME CORPORATION | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $18 |
Products named: ENTYVIO, DUPIXENT, REZDIFFRA, IBSRELA, OCALIVA, RINVOQ, OMVOH, VOQUEZNA.
Industry payments across SC — which companies pay providers there.
